CANTEX PHARMACEUTICALS, INC. — Form D
CANTEX PHARMACEUTICALS, INC. of WESTON, FL, a company, filed a Form D exempt-offering notice with the SEC on 2010-08-04. The offering totals $5.0M, of which $4.4M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2010-08-04
- Form: D
- Accession: 0001374961-10-000003
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $5.0M
- Amount sold: $4.4M
- Remaining: $606K
- Investors: 4
- Date of first sale: 2010-08-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-145926
Issuer
- Name: CANTEX PHARMACEUTICALS, INC.
- CIK: 0001374961
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 1792 BELL TOWER LANE, WESTON, FL, 33326
- Phone: 954-315-3660
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Myles D Greenberg | Director | Salt Lake City, UT |
| Christopher G Martin | Director | Tucson, AZ |
| Christopher A Kroeger | Director | Redwood City, CA |
| Todd C Brady | Director | CRANBURY, NJ |
| Claude G Bertrand | Executive Officer | Weston, FL |
| Stephen G Marcus | Director | Weston, FL |
| Stephen G Marcus | Executive Officer | Weston, FL |
| Neil A Flanzraich | Director | Weston, FL |
| Neil A Flanzraich | Executive Officer | Weston, FL |
Other filings by this issuer (3)
More